{
    "Symbol": "TAK",
    "AssetType": "Common Stock",
    "Name": "Takeda Pharmaceutical Co Ltd ADR",
    "Description": "Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals, over-the-counter drugs and quasi-drug consumer products, and other health care products. The company is headquartered in Tokyo, Japan.",
    "CIK": "1395064",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO, JP",
    "FiscalYearEnd": "March",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "44255048000",
    "EBITDA": "1174344958000",
    "PERatio": "44.68",
    "PEGRatio": "3.233",
    "BookValue": "4970.05",
    "DividendPerShare": "188",
    "DividendYield": "0.0422",
    "EPS": "0.31",
    "RevenuePerShareTTM": "1407.18",
    "ProfitMargin": "0.034",
    "OperatingMarginTTM": "0.159",
    "ReturnOnAssetsTTM": "0.0205",
    "ReturnOnEquityTTM": "0.0204",
    "RevenueTTM": "4413133947000",
    "GrossProfitTTM": "2441698000000",
    "DilutedEPSTTM": "0.31",
    "QuarterlyEarningsGrowthYOY": "0.049",
    "QuarterlyRevenueGrowthYOY": "0.141",
    "AnalystTargetPrice": "16.88",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "2",
    "AnalystRatingHold": "1",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "44.68",
    "ForwardPE": "23.04",
    "PriceToSalesRatioTTM": "0.0102",
    "PriceToBookRatio": "0.952",
    "EVToRevenue": "0.017",
    "EVToEBITDA": "0.0699",
    "Beta": "0.499",
    "52WeekHigh": "15.73",
    "52WeekLow": "12.57",
    "50DayMovingAverage": "13.27",
    "200DayMovingAverage": "13.87",
    "SharesOutstanding": "3169860000",
    "DividendDate": "2024-07-08",
    "ExDividendDate": "2024-03-27"
}